Workflow
股东回报规划
icon
Search documents
连亏三年,投资者质疑好想你高额分红
Guo Ji Jin Rong Bao· 2025-05-13 04:15
Core Viewpoint - The company, Hao Xiang Ni, reported a revenue of 1.67 billion yuan in 2024, a year-on-year decrease of 3.39%, and a net profit attributable to shareholders of -72 million yuan, a decline of 38.67%, marking three consecutive years of losses [1] Group 1: Financial Performance - In 2024, the company achieved a revenue of 1.67 billion yuan, down 3.39% year-on-year [1] - The net profit attributable to shareholders was -72 million yuan, representing a 38.67% decline compared to the previous year [1] - Cumulatively, the company has incurred losses exceeding 300 million yuan over the past three years, with net profits of -189 million yuan in 2021 and -52 million yuan in 2022 [1] Group 2: Dividend Policy - Despite consecutive losses, the company plans to distribute a cash dividend of 10 yuan per 10 shares, totaling approximately 432 million yuan for the 2024 fiscal year, along with an additional 173 million yuan in mid-year dividends, bringing the total to 605 million yuan [2] - The company's management stated that the dividend policy considers both investor demands and sustainable business operations, aiming to enhance shareholder returns and confidence [3] Group 3: Shareholding Structure - Approximately 30% of the high dividends are allocated to the founder's family, with the chairman holding 28.59% of the shares, and other family members holding a combined total of over 31% [4] - The chairman, Shi Jubin, and his family members are identified as acting in concert, indicating a significant influence over the company's decisions [4]
兴源环境: 第六届监事会第四次会议决议公告
Zheng Quan Zhi Xing· 2025-05-12 13:32
根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司证券 发行注册管理办法》等有关法律、法规及规范性文件的规定,经过对公司实际情 况及相关事项进行自查和论证,监事会认为公司各项条件符合现行法律、法规和 规范性文件中关于上市公司向特定对象发行股票的有关规定,具备本次向特定对 象发行股票的资格和条件。 证券代码:300266 证券简称:兴源环境 公告编号:2025-039 兴源环境科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 兴源环境科技股份有限公司(以下简称"公司")第六届监事会第四次会议 于2025年5月12日以通讯方式召开。会议通知已经于2025年5月9日以电子邮件方 式送达全体监事。本次会议应出席监事3人,实际出席监事3人。本次会议的通知、 召开以及参会监事人数均符合相关法律、法规、规则及《公司章程》的有关规定。 本次会议形成以下决议: 一、审议通过《关于公司符合向特定对象发行股票条件的议案》 本议案尚需提交公司股东大会审议。 表决结果:同意3票,反对0票,弃权0票。 二、逐项审议通过《关于公司2025年度向特定对象发行A股股 ...
司太立: 司太立:2024年度股东大会资料
Zheng Quan Zhi Xing· 2025-05-09 09:02
Core Viewpoint - Zhejiang Sitaili Pharmaceutical Co., Ltd. is preparing for its shareholder meeting scheduled for May 22, 2025, focusing on maintaining shareholder rights and ensuring orderly proceedings during the meeting [1][2]. Meeting Arrangements - The meeting will be held on May 22, 2025, at 14:30, with online voting available from 9:15 to 11:30 and 13:00 to 15:00 on the same day [3]. - The venue for the meeting is located at No. 9, Fengxi West Road, Modern Industrial Gathering Area, Xianju County, Zhejiang Province [3]. Shareholder Rights and Meeting Conduct - Shareholders have the right to speak, inquire, and vote, but must apply to the meeting's organizing committee to do so [2]. - The voting will be conducted via a named ballot, with each share granting one vote, and any improperly filled ballots will be considered as abstentions [2][3]. Board of Directors and Governance - The fifth board of directors consists of 7 members, including 3 independent directors, and has held 8 meetings during the reporting period to discuss various corporate matters [6]. - The board has focused on maintaining good governance and protecting shareholder interests through active discussions and independent opinions [6]. Financial Performance Overview - The company reported a steady growth in operating performance for 2024, with total assets reaching approximately 6.05 billion yuan, an increase of 9.59% compared to the previous year [15]. - The financial report indicates a decrease in cash and cash equivalents by 14.47% and a decline in accounts receivable by 10.76% [14][15]. Future Outlook - The company anticipates challenges in 2025 due to external factors such as safety and environmental risks, as well as increased competition in the industry [9]. - The board will closely monitor changes in external policies and economic conditions to provide strategic recommendations for sustainable development [9].
奥翔药业: 奥翔药业2024年年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-09 08:28
Meeting Information - The annual shareholders' meeting of Zhejiang Aoxiang Pharmaceutical Co., Ltd. is scheduled for May 20, 2025, at 14:00 [1] - The meeting will be held at the company's new office building in Linhai, Zhejiang [1] - Voting will be conducted through both on-site and online platforms [3] Shareholder Rights and Responsibilities - Shareholders must present identification and relevant documents to attend the meeting [2] - Shareholders have the right to speak, inquire, and vote during the meeting [2] - The meeting will follow a structured agenda, including the reading of proposals and voting on resolutions [2][3] Financial Performance - In 2024, the company reported a revenue of approximately RMB 795.29 million, a decrease of 2.63% from 2023 [18] - The net profit attributable to shareholders was approximately RMB 206.79 million, down 18.55% year-on-year [18] - The company's total assets increased by 1.04% to approximately RMB 2.98 billion, while net assets rose by 6.08% to approximately RMB 2.27 billion [18] Board of Directors' Report - The board emphasized a commitment to responsible governance and strategic decision-making to enhance shareholder value [4][6] - The board has established specialized committees to oversee various aspects of company operations, including audit and remuneration [6][7] Future Development Strategy - The company aims to leverage its R&D capabilities to capture opportunities in the global pharmaceutical market, particularly as many innovative drug patents expire [8] - The focus will be on developing high-value products and expanding into international markets [8][9] - The company plans to enhance its marketing strategies and strengthen customer relationships to ensure long-term growth [9] Profit Distribution Proposal - The board proposed a cash dividend of RMB 1 per 10 shares, totaling approximately RMB 82.83 million, which represents 40.05% of the net profit for 2024 [21]
荣盛石化(002493):公司业绩边际明显改善,股东回报增强彰显长期投资价值
Xinda Securities· 2025-04-30 12:31
Investment Rating - The investment rating for Rongsheng Petrochemical is "Buy" [1] Core Views - The company's performance has shown significant marginal improvement, and shareholder returns have enhanced its long-term investment value [1] - The report highlights that the refining and chemical industry is currently in a weak cycle, which may put short-term pressure on the company's performance [4] - The first quarter of 2025 saw a substantial improvement in the company's performance, indicating potential for profit elasticity [4][5] - The company has established a three-year shareholder return plan, emphasizing its long-term investment value [7] Financial Performance Summary - In 2024, the company achieved operating revenue of 326.475 billion yuan, a year-on-year increase of 0.42%, while net profit attributable to shareholders was 724 million yuan, a decrease of 37.44% [1] - The first quarter of 2025 reported operating revenue of 74.975 billion yuan, a year-on-year decrease of 7.54%, but net profit attributable to shareholders increased by 6.53% year-on-year [2] - The forecast for 2025-2027 indicates a significant recovery in net profit, with expected figures of 2.356 billion yuan, 2.783 billion yuan, and 3.935 billion yuan respectively, reflecting growth rates of 225.2%, 18.1%, and 41.4% [7] Industry Insights - The refining industry is entering a phase of stock competition, with a focus on "strong alliances" to create new development opportunities [4] - The average Brent crude oil price for 2024 is projected to be 79.86 USD/barrel, indicating a slight decrease from the previous year [4] - The report notes that the company is collaborating with Saudi Aramco, which is expected to enhance its global market presence and operational resilience [5]
雪松发展股份有限公司
2024年中喜会计师事务所购买的职业保险累计赔偿限额10,000.00万元,能够覆盖因审计失败导致的民事 赔偿责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 3、诚信记录 中喜所未受到刑事处罚。 中喜所近三年执业行为受到监督管理措施5次,21名从业人员近三年因执业行为受到监督管理措施共11 次。 中喜所近三年执业行为受到行政处罚1次,2名从业人员近三年因执业行为受到行政处罚共1次。 中喜所近三年执业行为受到纪律处分1次,2名从业人员近三年因执业行为受到纪律处分共1次。 (二)项目信息 1、中喜会计师事务所(特殊普通合伙)及其从业人员不存在违反《中国注册会计师职业道德守则》对 独立性要求的情形。项目组成员具备相应的专业胜任能力,主要成员信息如下: (1)项目合伙人:蒋建友,中国注册会计师,2002年注册,长期从事审计及与资本市场相关的专业服 务工作,具备相应专业胜任能力。 (2)拟任签字注册会计师:欧阳静波,中国注册会计师,2009年注册,长期从事审计及与资本市场相 关的专业服务工作,具备相应的专业胜任能力。 (3)项目质量控制复核人:黄颖君,中国注册会计师,2009年注册,长期从事审计及与资本市场相 ...
秋田微(300939) - 2025年04月29日投资者关系活动记录表(2024年度网上业绩说明会)
2025-04-29 09:48
证券代码:300939 证券简称:秋田微 深圳秋田微电子股份有限公司 投资者关系活动记录表 | 024-047)。后续如有股权激励计划,将严格按照相关规定及时履行信 | 息披露义务,敬请关注公司后续披露的相关公告。谢谢! | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 2.请问截止到 | 月 | 日收盘,公司股东人数是多少? | 4 | 29 | | | | | 答:尊敬的投资者,您好!根据中国证券登记结算有限责任公司下发 | 的《合并普通账户和融资融券信用账户前 | 名明细数据表》显示,截 | N | | | | | | 至 | 年 | 月 | 日,公司股份持有人数(已合并)为 | 14,951。谢谢! | 2025 | 04 | 18 | | 3.请问,自公司上市以来多年分红,后续的分红规划是什么? | | | | | | | | | 答:尊敬的投资者,您好!公司于 | 年 | 月 | 日披露了《未来三 | 2023 | 04 | 20 | 年(2023-2025)股东回报规划》。公司实行持续、稳定的利润分配政 | | 策 ...
泸州老窖(000568):2024年年报及2025年一季报点评:稳健经营,分红规划塑信心
Minsheng Securities· 2025-04-29 06:24
Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [7][8]. Core Views - The company reported a revenue of 31.196 billion yuan and a net profit of 13.473 billion yuan for 2024, reflecting year-on-year growth of 3.19% and 1.71% respectively. The fourth quarter of 2024 saw a decline in revenue and net profit, with year-on-year decreases of 16.86% and 29.86% respectively [3]. - The company adheres to a "dual brand, three product lines, and major products" strategy, with a focus on high-end liquor. The revenue from liquor operations reached 31.053 billion yuan, with a gross margin of 87.62%, showing a slight decline [4]. - The company has committed to a shareholder return plan, ensuring that cash dividends will account for at least 65% of net profit for 2024, 70% for 2025, and 75% for 2026, with a minimum total of 8.5 billion yuan in cash dividends each year [6][8]. Summary by Sections Financial Performance - For 2024, the company achieved a total revenue of 31.196 billion yuan, with a net profit of 13.473 billion yuan. The expected revenue for 2025 is projected at 31.883 billion yuan, with a net profit of 13.753 billion yuan, indicating a growth rate of 2.2% [9][10]. - The gross margin for 2024 was reported at 87.54%, with a slight decline expected in the following years [11]. Revenue Breakdown - The high-end liquor segment generated 27.585 billion yuan in revenue, while other liquor products contributed 3.467 billion yuan. The high-end segment saw a volume increase of 14.39% but a price decrease of 10.15% [4]. - The company’s revenue from traditional and emerging channels was 29.573 billion yuan and 1.479 billion yuan respectively, showing growth in both areas [4]. Shareholder Returns - The company plans to distribute a total cash dividend of 6.8 billion yuan for 2024, alongside a previously implemented 2 billion yuan interim dividend, meeting the 65% payout ratio requirement [8]. - The projected dividend yield for 2024 is 4.75%, reflecting the company's commitment to returning value to shareholders [6][8].
科沃斯(603486):利润超预期 发布未来三年股东回报规划
Xin Lang Cai Jing· 2025-04-29 02:40
Core Insights - The company reported better-than-expected profits for 2024 and Q1 2025, with a revenue of 16.542 billion yuan in 2024, a 7% year-on-year increase, and a net profit of 806 million yuan, a 32% increase [1] - The company plans to distribute a cash dividend of 0.45 yuan per share, totaling 259 million yuan, which is 32.12% of the net profit attributable to shareholders [1] Financial Performance - In Q4 2024, the company achieved a revenue of 6.316 billion yuan, a 27% year-on-year increase, and a net profit of 191 million yuan, a significant increase of 2178% [1] - For Q1 2025, the company reported a revenue of 3.858 billion yuan, an 11% year-on-year increase, and a net profit of 475 million yuan, a 59% increase [1] Business Segments - The company's domestic brands generated a revenue of 8.082 billion yuan, a 5.22% increase, while the Tanke brand achieved 8.061 billion yuan, a 10.87% increase, both accounting for 49% of total revenue [2] - The company successfully launched new products such as T30, T50, and X8, leading to a 47.5% year-on-year increase in shipments in Q4 2024 [2] International Expansion - The overseas revenue for both brands reached 6.808 billion yuan, a 12.6% increase, accounting for 42.2% of brand business revenue [2] - In the European market, the company saw significant growth, with revenues increasing by 51.6% for the Cobos brand and 64.0% for the Tanke brand [2] Cost Management - The company's gross margin remained stable, with a decrease in sales expense ratio by 3.84 percentage points, indicating effective cost control [2] - In Q1 2025, the company reported a reduction in R&D and financial expense ratios [2] Profit Forecast - The profit forecasts for 2025 and 2026 have been adjusted to 1.31 billion yuan and 1.56 billion yuan, respectively, with a new forecast for 2027 at 1.78 billion yuan, reflecting year-on-year growth of 63%, 19%, and 14% [3] - The company maintains a "buy" rating due to the introduction of new products and the growth contribution from overseas business [3]
顺丰控股(002352):2025年一季报点评:保持经营韧性,利润稳健增长
Xinda Securities· 2025-04-29 02:06
Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company has shown steady growth in domestic operations and is expanding its international business opportunities [1] - The first quarter of 2025 demonstrated resilience in operations with a revenue increase of 6.9% year-on-year, and a net profit growth of 16.87% [2][3] - The company is focusing on cost reduction and quality improvement, leading to a slight increase in net profit margins [3] - The logistics revenue increased by 7.2% year-on-year, while supply chain and international revenue grew by 9.9% [4] - The peak of capital expenditure has passed, resulting in a significant increase in free cash flow by 55.6% [5] - The company is expected to maintain strong profit growth in the coming years, with projected net profits of 119.11 billion, 142.57 billion, and 168.45 billion for 2025, 2026, and 2027 respectively [6] Financial Summary - In Q1 2025, the company achieved total revenue of 698.50 billion, with a year-on-year growth of 6.9% [2] - The net profit attributable to the parent company for Q1 2025 was 22.34 billion, reflecting a year-on-year increase of 16.87% [2] - The company’s operating cash flow for Q1 2025 was 40.62 billion, down 14.21% year-on-year [5] - The projected revenue for 2025 is 315.54 billion, with a growth rate of 10.9% [7] - The projected net profit for 2025 is 11.91 billion, with a growth rate of 17.1% [7] - The company’s gross margin is expected to improve to 14.0% by 2025 [7]